MiR-144-3p and Its Target Gene β-Amyloid Precursor Protein Regulate

Kuo Li1, Junling Zhang1, Chunxue Ji1

  • 1No. 2 Department of Neurology, Cangzhou Central Hospital, Cangzhou 061001, China .

Molecules and Cells
|June 23, 2016
PubMed

Insights

MicroRNAs (miRNAs), specifically miR-144-3p, are crucial for maintaining mitochondrial function in Parkinson

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Mitochondrial Biology

Background:

  • MicroRNAs (miRNAs) are implicated in neurodegenerative diseases.
  • Parkinson's disease (PD) involves mitochondrial dysfunction.
  • The role of hsa-miR-144-3p in PD pathogenesis is under investigation.

Purpose of the Study:

  • To investigate the role of hsa-miR-144-3p in Parkinson's disease.
  • To determine the relationship between miR-144-3p, APP, and mitochondrial function.

Main Methods:

  • Down-regulation of miR-144-3p observed in MPTP-treated SH-SY5Y cells.
  • Overexpression and silencing of miR-144-3p using miRNA-mimics and inhibitors.
  • Luciferase reporter assay to identify APP as a target gene.
  • Assessment of mitochondrial function markers (ATP, cell viability, mtDNA copy number, PGC-1α, NRF-1, TFAM).

Main Results:

  • miR-144-3p overexpression inhibited APP protein expression and improved mitochondrial function.
  • miR-144-3p up-regulation increased expression of PGC-1α, NRF-1, and TFAM, enhancing ATP levels, cell viability, and mtDNA copy number.
  • APP overexpression reversed the beneficial effects of miR-144-3p on mitochondrial function.

Conclusions:

  • hsa-miR-144-3p plays a protective role in maintaining mitochondrial function.
  • The identified target gene, APP, is involved in miR-144-3p-mediated mitochondrial regulation.
  • These findings suggest miR-144-3p as a potential therapeutic target for Parkinson's disease.